United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News Aptevo Therapeutics achieves major breakthrough with mipletamig in acute myeloid leukemia Aptevo Therapeutics has unveiled remarkable findings from Cohort 1 of its RAINIER clinical trial for mipletamig, a bispecific… byPallavi MadhirajuDecember 12, 2024